Skip to content

Effect of Prolonged Expressive Writing on Health Outcomes in Breast Cancer Patients Receiving Chemotherapy: A Multi-centre Randomized Controlled Trial

Effect of Prolonged Expressive Writing on Health Outcomes in Breast Cancer Patients Receiving Chemotherapy: A Multi-centre Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016278
Enrollment
Unknown
Registered
2018-05-24
Start date
2018-06-10
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

EW Group:The normal EW intervention based on Pennebaker: write at least 20 minutes over four consecutive days (4 sessions)
Prolonged EW Group:The prolonged EW intervention: write at least 20 minutes, 3 times a week, over a 4-week period (12 sessions)

Sponsors

Nanfang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) breast cancer patients diagnosed by pathologically; (2) underlying adjuvant chemotherapy, and the remaining chemotherapy cycles are more than one month; (3) able to write Chinese and physically able to write by hand for more than 20-minute periods; (4) Chinese fluency and have a primary education and above; (5) female, age older than 18 years; (6) patients who are expected to survive for more than 6 months; (7) signed informed consent.

Exclusion criteria

Exclusion criteria: (1) had a diagnosed psychiatric disorder; (2) combined with other cancer or other major diseases; (3) experienced major traumatic events like parents pass away during research period; (4) have been involved in other related studies.

Design outcomes

Primary

MeasureTime frame
Quality of life;

Secondary

MeasureTime frame
Psychological health wellbeing;Physical health-related outcomes;

Countries

China

Contacts

Public ContactChunlan Zhou

Nanfang Hospital of Southern Medical University

lanchun200488@126.com+86 13076874716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026